SOMERVILLE, NJ - Robert Wood Johnson University Hospital and Rutgers Cancer Institute of New Jersey are expanding their Gynecologic Oncology Program to the Somerset campus at the Steeplechase Cancer Center.
The new program at Robert Wood Johnson University Hospital Somerset will take a multidisciplinary approach to the treatment of and clinical research on cancers of the female reproductive system, according to a release. The cancers being studied include cervical, ovarian, uterine, vaginal, vulvar, fallopian tube, primary peritoneal and endometrial cancers, in addition to others.
The program, the release said, is a partnership with Rutgers Cancer Institute of New Jersey, and a team of specialized physicians will provide a full range of treatments.
The program at the Steeplechase Cancer Center will offer diagnosis, surgery, radiation oncology, chemotherapy, psychosocial services, genetic testing, palliative medicine, hospice care, educational programming and counseling to provide the most efficient care for the patients. Patients, the release said, will have access to highly specialized treatment techniques that are offered through Rutgers Cancer Institute of New Jersey, including brachytherapy, an advanced cancer treatment, and more.
“A cancer diagnosis can be a life-changing experience for patients and their families, and we want to be sure that we are providing every patient with the very best care and access to the most advanced, proven treatment techniques,” Stephen Jones, president and CEO of Robert Wood Johnson University Hospital and Robert Wood Johnson Health System, said in the release. “As a result of the merger that took place on June 1, we are very eager to expand the great care provided by the medical staff at the Somerville campus, and one of our first priorities is the implementation of this new program to improve cancer care, and provide our female patients with access to world-class specialists.”
“The Gynecologic Oncology Program will be a perfect addition to the already robust scope of care we provide at the Steeplechase Cancer Center, and will increase the quality of care provided to our patients battling gynecologic cancers,” Kathleen Toomey, medical director of the Steeplechase Cancer Center, added in the release. “Having the program in Somerville will allow for ease of access to some of the best gynecologic oncology physicians in the country and the latest clinical trials and treatment options available, bringing quality care and support closer to home.”